Arrowstreet Capital’s Vera Therapeutics VERA Stock Holding History

Arrowstreet Capital’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-22,179	Closed	-$956K	–	1786
2024 Q1	$956K	Buy	+22,179	New	+$790K	﹤0.01%	1328

Other funds holding VERA

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Arrowstreet Capital's VERA Position: Q2 2024 in Review

Arrowstreet Capital sold out of Vera Therapeutics (VERA) in Q2 2024, closing a stake of 22,179 shares — an estimated $956K sold.

Arrowstreet Capital first reported a position in VERA in Q1 2024 and held it in 1 quarter. The position peaked at $956K in Q1 2024. 171 funds tracked by Wall St. Rank hold VERA as of Q2 2024.

Arrowstreet Capital reported no remaining Vera Therapeutics position as of Q2 2024 after selling out during the quarter.
Arrowstreet Capital sold 22,179 Vera Therapeutics shares in Q2 2024, an estimated $956K.
Arrowstreet Capital first reported a position in Vera Therapeutics in Q1 2024 and held it in 1 quarter.
Arrowstreet Capital's Vera Therapeutics position peaked at $956K in Q1 2024.
171 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2024.

Based on Arrowstreet Capital's 13F filing for Q2 2024, filed 14 Aug 2024.